Browse Categories

Publications by authors named "Katie Kingwell"

  • Page 1 of 9
Na1.8 inhibitor poised to provide opioid-free pain relief.
Katie Kingwell

Nat Rev Drug Discov

January 2025

View Article and Find Full Text PDF
StitchR platform joins up gene therapy payloads.
Katie Kingwell

Nat Rev Drug Discov

January 2025

View Article and Find Full Text PDF
Multivalent vaccine tackles C. difficile.
Katie Kingwell

Nat Rev Drug Discov

December 2024

View Article and Find Full Text PDF
Antibody vanquishes SARS-CoV-2 variants.
Katie Kingwell

Nat Rev Drug Discov

December 2024

View Article and Find Full Text PDF
A viral-lipid hybrid delivery system for genetic therapies.
Katie Kingwell

Nat Rev Drug Discov

November 2024

View Article and Find Full Text PDF
FDA approves first schizophrenia drug with new mechanism of action since 1950s.
Katie Kingwell

Nat Rev Drug Discov

November 2024

View Article and Find Full Text PDF
RIPTACs expand anticancer target space.
Katie Kingwell

Nat Rev Drug Discov

October 2024

View Article and Find Full Text PDF
Splice-switching ASO curtails brain calcification.
Katie Kingwell

Nat Rev Drug Discov

October 2024

View Article and Find Full Text PDF
Muscarinic drugs breathe new life into schizophrenia pipeline.
Katie Kingwell

Nat Rev Drug Discov

September 2024

View Article and Find Full Text PDF
Molecular glue degrader for sickle cell disease.
Katie Kingwell

Nat Rev Drug Discov

September 2024

View Article and Find Full Text PDF
AI reverse-engineers antibodies.
Katie Kingwell

Nat Rev Drug Discov

September 2024

View Article and Find Full Text PDF
Antibody sniffs out tau.
Katie Kingwell

Nat Rev Drug Discov

September 2024

View Article and Find Full Text PDF
Rebalancing calcium in Alzheimer disease.
Katie Kingwell

Nat Rev Drug Discov

August 2024

View Article and Find Full Text PDF
Expanding the psychedelic toolkit.
Katie Kingwell

Nat Rev Drug Discov

July 2024

View Article and Find Full Text PDF
WRN inhibitors squeeze cancer cell vulnerability.
Katie Kingwell

Nat Rev Drug Discov

June 2024

View Article and Find Full Text PDF
FDA approves Merck & Co's pulmonary arterial hypertension drug sotatercept.
Katie Kingwell

Nat Rev Drug Discov

May 2024

View Article and Find Full Text PDF
AI serves up target and inhibitor for lung fibrosis.
Katie Kingwell

Nat Rev Drug Discov

May 2024

View Article and Find Full Text PDF
NASH field celebrates 'hurrah moment' with a first FDA drug approval for the liver disease.
Katie Kingwell

Nat Rev Drug Discov

April 2024

View Article and Find Full Text PDF
Ribosome-targeted antibiotic tackles antimicrobial resistance.
Katie Kingwell

Nat Rev Drug Discov

April 2024

View Article and Find Full Text PDF
BMP9 stands up to sepsis.
Katie Kingwell

Nat Rev Drug Discov

March 2024

View Article and Find Full Text PDF
Targeting glial lipid metabolism to tackle neurodegeneration.
Katie Kingwell

Nat Rev Drug Discov

February 2024

View Article and Find Full Text PDF
γ-secretase inhibitor notches first approval.
Katie Kingwell

Nat Rev Drug Discov

January 2024

View Article and Find Full Text PDF
Gene therapy zeroes in on Parkinson disease brain circuits.
Katie Kingwell

Nat Rev Drug Discov

January 2024

View Article and Find Full Text PDF
A new shuttle for drug delivery across the blood-brain barrier.
Katie Kingwell

Nat Rev Drug Discov

December 2023

View Article and Find Full Text PDF
A step closer to in vivo editing of haematopoietic stem cells.
Katie Kingwell

Nat Rev Drug Discov

October 2023

View Article and Find Full Text PDF
Privacy Policy Site Map

© LitMetric 2025. All rights reserved.